Supplementary Data from Phase II, Open-Label Study of Brivanib As First-Line Therapy in Patients with Advanced Hepatocellular CarcinomaJoong-Won Park,Richard S. Finn, Jun Suk Kim,Mark Karwal,Ruby K. Li,Fuad Ismail, Melanie Thomas,Rosemarie Harris,Christine Baudelet, Ian Walters,Jean-Luc Raoulcrossref（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
